Kairntech’s Post

🗓️ Save the date - December 11th, 1PM Eastern time - for the last Lantern Pharma Webinar Wednesday of the year - Power of AI in Drug Development – Predicting Blood Brain Barrier Permeability with RADR.   https://bit.ly/4gy7jtF https://bit.ly/4gy7jtF Featuring Rick Fontenot, data scientist of Lantern Pharma Inc. (Nasdaq: LTRN), we will be discussing 📍 What is Blood Brain Barrier and why is it so important? 📍 RADR AI insights on BBB -using machine learning : How did we build BBB models and how accurate is it? 📍 Power of predicting BBB permeability with RADR …and so much more! Register now: https://bit.ly/4gy7jtF to join the free webinar!

🚀 We’re thrilled to launch Moremi AI and Moremi Bio, our multimodal large language models advancing towards Artificial General Intelligence for Health & Biology and Health-first AGI! 🌍💡 Moremi AI covers medical tasks like diagnosis and treatment planning, while Moremi Bio focuses on toxicology, molecule generation, and outcome predictions in clinical  trials. We’re also sharing insights on current limitations and safety measures. Check out the link below to learn more! 👇 https://lnkd.in/dXDmB5C5

Exciting News! 📢 Join Parashar Dhapola, our CEO on October 9, 2024, at 17:00 at BioTechX Europe, where he'll dive into the future of single-cell analytics and its with AI and foundation models. Expect insights into how Nygen is integrating data and AI to accelerate target discovery in early drug discovery pipelines and beyond.   Want to learn more? Visit us at 📍booth 502 and sign up for a free demo if you're curious how Nygen’s single-cell and multi omics analytics solutions can transform your research!   #BioTechX #NygenAnalytics #AI #Genomics #Innovation #SingleCellAnalysis

An exciting webinar to watch on AI and acceleration of Drug Development....

With the AAIH Annual Member Meeting only a few weeks away, we would like to spotlight the panels that will take place over the course of the 2-day meeting! On September 30th 2024, the "Pharma Drug Discovery & Development AI Strategy" panel will take place, featuring Aliza Apple. Hear from R&D Leaders on new emerging AI research in their organizations and the latest AI use cases being deployed, such as biology foundation models, generative molecular design, research co-pilots, federated learning for data and model sharing, and large language models to aid in clinical trials. Hear how these leaders are innovating within their organizations, what they look for in external collaborations, where they see the biggest near-term impact, and the future of drug discovery and development. If you have not yet registered for the AAIH Annual Member meeting, both members and non-members can do so at https://lnkd.in/gdfZCEWY

At AstraZeneca, learning and development are directly linked to how we create a culture of continuous growth and innovation. As our world becomes more integrated with technology, our teams are encouraged to learn more about how to use generative AI tools in an ethical way so we can be more agile and evolve our ways of work as we continue to push the boundaries of science to deliver life-changing medicines to patients. Discover more about our journey to upskill our team for the age of AI and how it fits within our wider learning and development philosophy. https://lnkd.in/ejr7tspQ

✨ Are you attending the AI Driven Drug Discovery Summit next week? Yao Fehlis, PhD, the Head of AI at Artificial, will be at the show. Reach out so you can connect! #artificialinc #ai #AIDDD #aidrugdiscovery

I'm very excited to announce this partnership between Dotmatics and Databricks. Combining scientific intelligence with data intelligence is key to tackling the growing complexity and scale of scientific R&D. Today's scientific workflows generate and consume large amounts of disconnected data, making it difficult to reason about outcomes and leverage AI. This partnership represents our intention to bring the best technologies together to help solve this problem. I hope you'll come to our joint webinar next Wednesday, December 18th "Building Breakthroughs: Harnessing Data and AI for Innovation" to learn more.

If you are passionate about AI & Medical Imaging and want to learn more about the latest breakthrough in Pharma. Come & join our session #BioTechX In this session, I will present our latest work at #Bayer in Synthetic Medical Imaging. #MedicalImaging #ComputerVision #MachineLearning #Bayerteam #GenerativeAI

At ViQi we’ve embraced predictive AI as the next step in the natural evolution of using software to drive progress. We’re not interested in replacing humans and their creative, novel thinking with AI; rather, we want to make the impossible possible. In the past several decades people have mastered generating data using computers built into every tool we use in our daily lives whether that be in our jobs, at our homes with our families, or going out for a night on the town. But what do we do with all of that data? Engineers, scientists, and business leaders are getting better at defining metrics and goals and then using the data to monitor the path to achieving those goals. But we’re now producing far more data than we can meaningfully use even with the tools and capabilities we developed over the last several years. Until now. This is where predictive AI comes in. Eric Siegel wrote this great article (https://lnkd.in/gPi9cuXp) for Forbes describing the difference between generative and predictive AI, pointing out the value of predictive AI. This aligns with how the team at ViQi is thinking about this space. Checkout what we’re doing at ViQi (viqiai.com) to advance scientific answers using predictive AI technology.